BIVI - BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease
BIVI - BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease
Story updates
11:31:23 AM UTC
SquawkNews
BIVI BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson's Disease
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.